The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current revenue (TTM) is $28.19 B. In 2022 the company made a revenue of $26.32 B an increase over the years 2021 revenue that were of $25.97 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $28.19 B | 7.09% |
2022 | $26.32 B | 1.32% |
2021 | $25.97 B | 2.18% |
2020 | $25.42 B | 8.83% |
2019 | $23.36 B | -1.62% |
2018 | $23.74 B | 3.93% |
2017 | $22.84 B | -0.62% |
2016 | $22.99 B | 6.14% |
2015 | $21.66 B | 7.97% |
2014 | $20.06 B | 7.43% |
2013 | $18.67 B | 8.17% |
2012 | $17.26 B | 10.8% |
2011 | $15.58 B | 3.51% |
2010 | $15.05 B | 2.81% |
2009 | $14.64 B | -2.41% |
2008 | $15.00 B | 1.57% |
2007 | $14.77 B | 3.53% |
2006 | $14.26 B | 14.79% |
2005 | $12.43 B | 17.82% |
2004 | $10.55 B | 26.26% |
2003 | $8.35 B | 53.51% |
2002 | $5.44 B | 37.51% |
2001 | $3.95 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 229.98% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 107.51% | ๐บ๐ธ USA |
AbbVie ABBV | $54.31 B | 92.69% | ๐บ๐ธ USA |
Eli Lilly LLY | $34.12 B | 21.05% | ๐บ๐ธ USA |
Biogen BIIB | $9.66 B | -65.72% | ๐บ๐ธ USA |
Gilead Sciences GILD | $27.11 B | -3.81% | ๐บ๐ธ USA |
Illumina ILMN | $4.50 B | -84.02% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.53 B | 61.53% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $37.84 B | 34.26% | ๐ฌ๐ง UK |